Proactive Patient Review in Diabetes

People with type 2 diabetes (T2D) are 50% more likely to die prematurely than those without diabetes1. A common complication of diabetes that can lead to early death is cardiovascular disease (CVD). People with T2D are two to two-and-a-half times more likely to experience heart failure and twice as likely to have a heart attack compared to people without diabetes. At least 10% of the entire NHS budget is spent on diabetes each year, and almost 80% of this is spent on treating complications.

Marsh Medical practice wished to adopt a proactive approach to optimising the management of patients with T2D, with a focus on CVD risk and status. The practice commissioned Interface Clinical Services, an IQVIA business, to perform the review and provide additional resource to help ensure continuity of care for patients during the COVID pandemic.

The aim of this service was to support Marsh Medical Practice to improve the quality of care, safety, and management of patients with T2D through proactive assessment of patients with a diagnosis of T2D. This was achieved by:

• Stratifying patients with a diagnosis of T2D according to CVD risk and status, and current glycaemic control
• Pharmacist-led reviews for patients identified as at risk of poor outcomes
• Provision of reports to support the practice in driving and maintaining quality improvement for patients with T2D

View the full case study below.